跳至主要内容
临床试验/NCT07286513
NCT07286513
Enrolling By Invitation
不适用

A Prospective, Multi-Center Post-Market Clinical Study Evaluating the Safety, Performance, and Clinical Benefits of the Persona® SoluTion® PPS Femur

Zimmer Biomet1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年2月26日最近更新:

概览

阶段
不适用
状态
Enrolling By Invitation
发起方
Zimmer Biomet
入组人数
200
试验地点
1
主要终点
Change in KOOS JR Score between pre-op and 2 years post-op

概览

简要总结

The goal of this study is to generate clinical evidence and evaluate the safety and performance of the Persona® SoluTion® PPS Femurs in the US market, with data supporting global regulatory submissions, including CE marking under EU MDR.

The target population consists of adults undergoing knee arthroplasty with the Persona SoluTion femoral component paired with a Medial Congruent (MC) or Posterior Stabilized (PS) articulating surface in line with its current cleared Instructions for Use (IFU).

The primary endpoint is the assessment of clinical performance and benefits by evaluating the average change in the KOOS JR score between pre-operative and 2-year post-operative follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is of legal age of consent and skeletally mature
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB/EC approved Informed Consent document
  • Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  • Patient qualifies for total knee arthroplasty based upon physical exam and medical history and meets the approved indications for use of the Persona® SoluTion® PPS femoral implant and appropriate compatible components, within a pre-specified variant configuration (cohort).
  • A clinical decision has been made to use the Persona® SoluTion® PPS femoral implant prior to enrollment in the research

排除标准

  • Patient is currently participating in any other surgical intervention or pain management study
  • Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
  • Patient has a mental or neurologic condition who is unwilling or incapable of following postoperative care instructions
  • Patient has a condition which would, in the judgement of the Investigator, place the patient at undue risk or interfere with the conduct of the study
  • Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
  • Previous history of infection in the affected joint and/or other local/systematic infection that may affect the prosthetic joint
  • Insufficient bone stock on femoral or tibial surfaces
  • Skeletal immaturity
  • Neuropathic arthropathy
  • Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb

研究组 & 干预措施

Persona® SoluTion PPS CR Femur with MC Bearing, cementless

This cohort will consist of subjects who receive the Persona® SoluTion PPS Cruciate Retaining Femur with the Medial Congruent Bearing, with cementless fixation.

干预措施: Total knee arthroplasty (Device)

Persona® SoluTion PPS PS Femur with PS Bearing, cementless

This cohort will consist of subjects who receive the Persona® SoluTion PPS Posterior Stabilized Femur with the Posterior Stabilized Bearing, with cementless fixation.

干预措施: Total knee arthroplasty (Device)

Persona® SoluTion PPS CR or PS Femur, cemented

This cohort will consist of subjects who receive the either the Persona® SoluTion PPS Cruciate Retaining Femur (with the Medial Congruent Bearing) or Posterior Stabilized Femur (with the Posterior Stabilized Bearing), with cemented fixation.

干预措施: Total knee arthroplasty (Device)

结局指标

主要结局

Change in KOOS JR Score between pre-op and 2 years post-op

时间窗: 2 years

A 7-item shortened version of the Knee injury and Osteoarthritis Outcome Score (KOOS), specifically designed to assess knee health in patients undergoing total knee arthroplasty (TKA). Raw scores are converted to an interval score ranging from 0 to 100, where 0 represents complete knee disability and 100 represents perfect knee health (higher scores indicate less pain and better function).

次要结局

  • KOOS JR Score(5 years)
  • Oxford Knee Score (OKS)(5 years)
  • EuroQol-5 Dimension-5 Level (EQ-5D-5L) Questionnaire(5 years)
  • Numeric Rating Scale (Pain)(5 years)
  • Survival Rate of Implant(10 years)
  • Frequency and types of Adverse Events(10 years)
  • Assessment of the prevalence of metal hypersensitivities using a metal Lymphocyte Transformation Test (LTT)(10 years)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验